Madrigal Pharmaceuticals Inc (MDGL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$10.05B
EV to revenue ratio (TTM)
6.08
EV to ebitda
-8.32
Financial Performance
Revenue (TTM)
$1.43B
Gross profit (TTM)
$1.30B
EBITDA
-$0.15B
Profitability
Operating margin (TTM)
13.00%
Profit margin
-10.90%
Return on assets (TTM)
-6.82%
Return on equity (TTM)
-24.80%
Per Share Metrics
Revenue per share (TTM)
$61.86
EPS
-$5.85
Diluted EPS (TTM)
-$5.85
Book value
$27
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
57.47
PEG ratio
0
Price to sales ratio (TTM)
7.04
Price to book ratio (TTM)
14.81
Growth
Quarterly earnings growth (YoY)
50.10%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
3
Buy
15
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
-1.00